The protective role of bone morphogenetic protein-8 in the glucocorticoid-induced apoptosis on bone cells

Bone

Volumn 48, Issue 5, 2011, Pages 1052-1057

  Kósa, János P ^a   Kis, Adrián ^a   Bácsi, Krisztián ^a   Balla, Bernadett ^a   Nagy, Zsolt ^a   Takács, István ^a   Speer, Gábor ^a   Lakatos, Péter ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

BMP 8; Calvarial osteoblast; Glucocorticoid induced osteoporosis; MC3T3 E1; SiRNA; Transcriptional profiling

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 8; DEXAMETHASONE; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BMP 8 GENE; BONE CELL; BONE METABOLISM; BONE REMODELING; CALVARIA; CELL PROTECTION; CELL STRAIN 3T3; CELL VIABILITY; CONTROLLED STUDY; GENE; GENE EXPRESSION PROFILING; MATRIX METALLOPROTEINASE 2 GENE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROTEIN FUNCTION; RNA INTERFERENCE; SMAD3 GENE; TYPE 2 COLLAGEN ALPHA 1 GENE; TYPE 9 COLLAGEN ALPHA 1 GENE;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; BIOLOGICAL ASSAY; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEINS; CASPASE 3; CASPASE 7; CELL SURVIVAL; CYTOPROTECTION; DEXAMETHASONE; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GLUCOCORTICOIDS; MICE; OSTEOBLASTS; RNA, SMALL INTERFERING; SKULL; TIME FACTORS;

EID: 79954585152     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.01.017     Document Type: Article

References (29)

1. Zhao G.Q., Liaw L., Hogan B.L. Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis. Development 1998, 125(6):1103-1112.
2. Manolagas S.C., Weinstein R.S. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J. Bone Miner. Res. 1999, 14(7):1061-1066.
3. Dempster D.W., Arlot M.A., Meunier P.J. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif. Tissue Int. 1983, 35(4-5):410-417.
4. Dykman T.R., et al. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 1985, 28(4):361-368.
5. Ross E.J., Linch D.C. Cushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 1982, 2(8299):646-649.
6. Adinoff A.D., Hollister J.R. Steroid-induced fractures and bone loss in patients with asthma. N. Engl. J. Med. 1983, 309(5):265-268.
7. Newman E.D., et al. Glucocorticoid-Induced Osteoporosis Program (GIOP): a novel, comprehensive, and highly successful care program with improved outcomes at 1year. Osteoporos. Int. 2006, 17(9):1428-1434.
8. Canalis E. Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J. Clin. Endocrinol. Metab. 1996, 81(10):3441-3447.
9. Weinstein R.S., et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 1998, 102(2):274-282.
10. Beavan S., et al. Colocalization of glucocorticoid and mineralocorticoid receptors in human bone. J. Bone Miner. Res. 2001, 16(8):1496-1504.
11. Patschan D., Loddenkemper K., Buttgereit F. Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 2001, 29(6):498-505.
12. Smith E., Coetzee G.A., Frenkel B. Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta. J. Biol. Chem. 2002, 277(20):18191-18197.
13. Furlan F., et al. Proliferation, differentiation and apoptosis in connexin43-null osteoblasts. Cell Commun. Adhes. 2001, 8(4-6):367-371.
14. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factors 2004, 22(4):233-241.
15. Zhao G.Q., et al. The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes Dev. 1996, 10(13):1657-1669.
16. Zhao G.Q., Hogan B.L. Evidence that mouse Bmp8a (Op2) and Bmp8b are duplicated genes that play a role in spermatogenesis and placental development. Mech. Dev. 1996, 57(2):159-168.
17. Ying Y., et al. Requirement of Bmp8b for the generation of primordial germ cells in the mouse. Mol. Endocrinol. 2000, 14(7):1053-1063.
18. Andrieux J., et al. Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis. Cancer Genet. Cytogenet. 2007, 178(1):11-16.
19. Sulzbacher I., et al. The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter. J. Clin. Pathol. 2002, 55(5):381-385.
20. Shin S.S., et al. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts. J. Hand Surg. Am. 2004, 29(5):809-814.
21. Henderson L.J., et al. Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells. Br. J. Cancer 2005, 92(8):1553-1560.
22. Cho T.J., Gerstenfeld L.C., Einhorn T.A. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J. Bone Miner. Res. 2002, 17(3):513-520.
23. Iu M.F., et al. Dexamethasone suppresses Smad3 pathway in osteoblastic cells. J. Endocrinol. 2005, 185(1):131-138.
24. Furumatsu T., et al. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J. Biol. Chem. 2005, 280(9):8343-8350.
25. Sowa H., et al. Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells. J. Bone Miner. Res. 2002, 17(7):1190-1199.
26. Borton A.J., et al. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J. Bone Miner. Res. 2001, 16(10):1754-1764.
27. Wu J.J., Eyre D.R. Intervertebral disc collagen. Usage of the short form of the alpha1(IX) chain in bovine nucleus pulposus. J. Biol. Chem. 2003, 278(27):24521-24525.
28. Wang C.J., et al. Trabecular bone deterioration in col9a1+/- mice associated with enlarged osteoclasts adhered to collagen IX-deficient bone. J. Bone Miner. Res. 2008, 23(6):837-849.
29. Okamoto M., et al. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J. Bone Miner. Res. 2006, 21(7):1022-1033.